Health & Biotech
MGC Pharmaceuticals (ASX: MXC) has changed its name to Argent Biopharma - RGT (ASX: RGT).
Below are the previous articles from MGC Pharmaceuticals (ASX: MXC):
RELATED STOCKHEAD STORIES
Health & Biotech
Stock Insiders: MGC Pharmaceuticals’ ‘golden blanket’ combines multiple elements for better patient efficacy
Health & Biotech
MGC Pharma takes 40pc stake in ZAM, an AI healthcare platform that’s ‘ahead of market peers’
Health & Biotech
MGC Pharma’s shares spike more than 20pc on positive trial of ArtemiC Support into Long Covid
Health & Biotech
ASX Health Stocks: MXC tests positive in South Africa for COVID-19; NTI high on cannabis v autism in kids
Health & Biotech
Encouraging signs for MGC Pharma after cannabinoid treatment for aggressive brain cancer breakthrough
Health & Biotech
Weed Week: Cannabis-feed for chickens and cannabis campaigner nabs Queen’s Birthday honour
News
Closing Bell: Small caps show big heart with unlikely rise
Health & Biotech
MGC Pharma results provides real hope for Alzheimer’s sufferers
Health & Biotech
Weed Week: Woody Harrelson opens weed dispensary and Byron Bay could be home to a cannabis resort
News
Weed Week: New Yorkers with cannabis convictions first in line for retail licences, CBX Stock Exchange launches
Stockhead TV
V-Con: Medicinal cannabis – which global firms will take the $US35 billion cake?
Health & Biotech
Punching the lights out: Best half year ever for MGC Pharma as it triples revenue, aims to convert clinical trials to sales
Health & Biotech
ASX Health Stocks: Cannabis biotech Avecho begins dosing patients in CBD gel study to treat osteoarthritis
News
Closing Bell: The ASX lifts with all sectors finishing in the green
Health & Biotech
This fundie reckons MGC Pharma can soar well over 3x current share price
News
Here’s what CEOs are hoping to change with their New Year’s resolutions for 2022
News